Interestingly, in other aggressive human tumors, such as melanoma and glioblastoma, TGFβ signaling is maintained in cancer cells, mainly through non-canonical signaling cascades (PI3K/AKT and RAS/MAPK pathways) 38. This evidence concerns the gene TGFB1 and melanoma.